G. Pappagallo and M. Rizzo, “Directness and quality of evidence of bevacizumab combined with chemotherapy for platinum-resistant, recurrent ovarian cancer in the AURELIA trial:  ”, CBN, vol. 2, no. 2, pp. 39–41, Oct. 2014.